Press Releases Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
1.81 ^USD	-2.69%		+4.02%	+13.12%

May. 07	Reneo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 28	Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results	May. 07	GL
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update	Mar. 28	GL
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	Dec. 14	GL
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	Dec. 14	AQ
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results	Nov. 13	GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	Nov. 02	GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	Nov. 02	AQ
Women in Stem with Ashley Hall	23-10-31	AQ
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings	23-10-25	GL
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings	23-10-25	AQ
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	23-10-09	GL
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)	23-10-09	AQ
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit	23-10-06	GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	23-08-29	GL
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences	23-08-29	AQ
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results	23-08-10	GL
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results	23-08-10	AQ
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum	23-06-30	GL
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum	23-06-30	AQ
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices	23-06-26	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Press Releases

Filters